Madden Center for Value Creation: Entrepreneurship & Longevity Conference

2nd Annual Entrepreneurship, Longevity, and Biotech Conference

The Madden Center for Value Creation at FAU is excited to host its second annual Entrepreneurship, Longevity, and Biotech Conference on Friday and Saturday, February 9-10, 2024 at the Schmidt Family Complex, Florida Atlantic University. We are honored to have distinguished speakers, including Dr. Carmela Abraham, Bryan Johnson, and Nathan Cheng, and more. These experts, along with other world-renowned speakers, will delve into the significant impact of the biotech industry. With an expected attendance of over 150 innovators, investors, and intellectually curious individuals, this promises to be a pivotal event for all involved.

During the first annual Entrepreneurship, Longevity, and Biotech Conference, attendees heard a range of discussions, from investing in longevity to the science of startups. Speakers shared their expertise and experiences, delving into the latest developments in the industry, including gene therapy, companies that impact longevity research, and treatment delivery through nanosized delivery systems. These discussions explored how to optimize regenerative, personalized, and precision medicine, providing valuable insights into the future of the biotech and longevity industries.

2024 Conference Agenda

Speakers Will Include:

Dr. Carmela Abraham, Chief Science Officer, ADvantage Therapeutics, Inc.

Omar Abudayyeh, McGovern Fellow at Massachusetts Institute of Technology

Nathan Cheng, General Partner, Healthspan Capital

Yuri Deigin, Co-Founder, YouthBio Therapeutics

Lisa Fabiny-Kiser, CEO, SENS Research Foundation

Agustin Fernandez III, CEO, Rational Vaccines

Leonardo Ferreira, Assistant Professor, Medical University of South Carolina

Iosif Gershteyn, Founder and CEO, ImmuVia

Jonathan Gootenberg, McGovern Fellow at Massachusetts Institute of Technology

Dr. Daniel Gropper, Dean, Florida Atlantic University, College of Business

Dr. Jean Hebert, Professor, Albert Einstein College of Medicine

Bryan Johnson, Founder and CEO, Blueprint

Dr. Leona Kroehle, CEO and Founder, Bluezone Longevity Sphere

Dr. Makoto Kuro-o, Division of Anti-Aging Medicine, Jichi Medical University, Japan

Jeff Madden, CEO, ADvantage Therapeutics, Inc.

Dr. Jose Navarro, Scientific Director and Partner, Quadrascope

Jim O'Neill, Former Health and Human Services Principal Associate Deputy Secretary

Dr. Achim Schneeberger, Chief Medical Officer, ADvantage Therapeutics, Inc.

Petr Sramek, CEO, Healthy Longevity Clinic, Managing Partner at VC Longevity Tech Fund

Dr. Rudy Tanzi, Professor of Neurology, Harvard Medical School, Director of the Genetics and Aging Research Unit, MGH

Dr. Siri Terjesen, Phil Smith Professor, Associate Dean of Research & External Relations, Executive Director, Madden Center for Value Creation at Florida Atlantic University

Andre Watson, Chairman and CEO, Ligandal

Speaker roster is subject to change. For registration information email maddencenter@fau.edu

Inaugural Entrepreneurship, Longevity, and Biotech Conference 2023

On March 24, 2023, we hosted the inaugural Madden Center hosted the Entrepreneurship, Longevity, and Biotech Conference. This event gave attendees the opportunity to connect with innovators, pharmaceutical and biotechnology executives, investors, and regulatory experts from the FDA in a series of roundtables and open-ended discussions with the aim of fostering an innovation ecosystem and the next generation of precision medicine and longevity.

Sponsored by the FAU Madden Center for Value Creation and FAU Health.

Entepreneurship and Longevity

Speakers Included:

Bob Langer (Keynote), David H. Koch Institute Professor, Massachusetts Institute of Technology, Co-Founder of Moderna

Diane Abbitt, Attorney, Start-Ups and Biotech

Omar Abudayyeh, McGovern Institute Fellow at Massachusetts Institute of Technology, Co-Principal Investigator of the Abudayyeh Gootenberg Lab, Co-Founder, Sherlock Biosciences, Co-Inventor, CRISPR

Janice Chen, Co-Founder & CTO, Mammoth Biosciences

Nathan Cheng, Executive Director, Longevity Biotech at On Deck

Allison Duettman, CEO, Foresight Institute

Chandra Duggirala, Co-Founder, CEO at FounderPool

Amanda Elam, CEO & Co-Founder, Galaxy Diagnostics

Leonardo Ferreira, Assistant Professor at Medical University of South Carolina, Post-Doc, Bluestone Lab, University of California - San Francisco

Agustin Fernandez III, CEO, Rational Vaccines

Jonathan Gootenberg, McGovern Institute Fellow at Massachusetts Institute of Technology, Co-Principal Investigator of the Abudayyeh Gootenberg Lab, Co-Founder, Sherlock Biosciences, Co-Inventor, CRISPR

Eric Hargan, Former Deputy Secretary - HHS, Founder & CEO of The Hargan Group

Bryan Johnson, Founder & CEO of Blueprint

Geoffrey Ling, Founding Director, DARPA Biological Technologies Office, CEO, On Demand Pharmaceuticals, Inc.

Jeff Madden, CEO, ADvantage Therapeutics, Inc., Former RMB Capital, Former Partner - Iron Bridge Capital Management

Jim O'Neill, Co-founder, the Thiel Fellowship, Former HHS Official

James Peyer, CEO, Cambrian Bio

Walter Schmidt, Director, mRNA Division, ADvantage Therapeutics

Richard Serbin, Former Global Head of Corporate Development for Johnson & Johnson, Regulation and Patent Attorney, Pharmacist

Alfred Slanetz, President & CEO, Geneius Biotechnology, Inc.

Siri Terjesen, Phil Smith Professor, Associate Dean of Research & External Relations, Executive Director, Madden Center for Value Creation at Florida Atlantic University